Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kanuka oil is a botanical extract derived from the leaves of the *Kunzea ericoides* tree, which is native to New Zealand. It is a complex mixture of terpenes, including high concentrations of alpha-pinene, viridiflorol, and leptospermone, which contribute to its antimicrobial, antifungal, and anti-inflammatory properties. In clinical development, specifically by Nexgen Dermatologics, a 3% topical formulation of kanuka oil is being investigated as a treatment for mild atopic dermatitis. It is positioned as a natural, over-the-counter alternative to topical corticosteroids like hydrocortisone, aiming to alleviate pruritus and skin inflammation while potentially modulating the skin microbiome to reduce colonization by pathogens such as *Staphylococcus aureus*.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on kanuka oil.